Hong Kong Construction Stock News

SEHK:23
SEHK:23Banks

How Investors May Respond To Bank of East Asia (SEHK:23) Scaling UiPath-Powered Automation Across Core Operations

Bank of East Asia has already embedded UiPath robotic process automation into its production operations and testing workflows, aiming to stabilise complex processes, reduce error rates, and improve data movement between systems while strengthening risk controls. The bank reports that these UiPath deployments have saved more than 553,000 aggregated processing hours and plans to expand automation through citizen development across the organisation, highlighting how deeply automation is being...
SEHK:1128
SEHK:1128Hospitality

Assessing Wynn Macau (SEHK:1128) Valuation After Macau’s Strong January Gaming Revenue Surprise

Macau’s January gross gaming revenue beat estimates, and that sector wide surprise helped lift casino names even as the broader market softened. Wynn Macau (SEHK:1128) inched up 0.86%, drawing fresh attention to the stock. See our latest analysis for Wynn Macau. At a share price of HK$6.08, Wynn Macau’s recent 7 day share price return of 5.01% contrasts with a 90 day share price decline of 7.03%. Over 1 year, the total shareholder return of 24.76% sits against weaker 3 and 5 year total...
SEHK:2269
SEHK:2269Life Sciences

WuXi Biologics Alliances Deepen Role In Complex Autoimmune And Fusion Drugs

WuXi Biologics (Cayman) (SEHK:2269) announced new alliances with Vertex Pharmaceuticals and Sinorda Biomedicine for co-development and manufacturing of biologics targeting autoimmune diseases. The company also expanded its agreement with HanchorBio to cover next generation fusion protein programs. Together, these collaborations broaden WuXi Biologics' role as a global contract research, development and manufacturing partner across multiple therapeutic modalities. WuXi Biologics focuses on...
SEHK:175
SEHK:175Auto

Did Ford–Geely Valencia Talks Just Reframe Geely Automobile Holdings' (SEHK:175) European Manufacturing Ambitions?

In recent days, Ford Motor confirmed it is in talks with Zhejiang Geely Holding Group about using Ford’s excess plant capacity in Valencia, Spain, potentially including platform and technology sharing for European vehicle production. This prospective collaboration could allow Geely to assemble cars within the European Union, helping reduce tariff exposure while giving Ford a way to improve utilisation of its underused facilities. Next, we examine how this potential Ford manufacturing tie-up,...
SEHK:867
SEHK:867Pharmaceuticals

Assessing China Medical System Holdings (SEHK:867) Valuation After CMS D017 Clinical Trial Approval

China Medical System Holdings (SEHK:867) has secured approval from China's National Medical Products Administration to start clinical trials for CMS-D017, an oral complement factor B inhibitor targeting paroxysmal nocturnal hemoglobinuria. See our latest analysis for China Medical System Holdings. Trading at HK$14.58, China Medical System Holdings has seen firm momentum recently, with a 7 day share price return of 4.59%, a 30 day share price return of 7.44%, and a 1 year total shareholder...